Malignant jugulotympanic paraganglioma

Summary

Malignant jugulotympanic paraganglioma (MONDO:0006291) is a disease. A subtype of vascular cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant jugulotympanic paraganglioma
Mondo ID	MONDO:0006291
NCIT	C4623
UMLS	C0347856
MedGen	87584
GARD	0024363
Anatomy (UBERON)	UBERON:0034972
Is cancer (heuristic)	no

Also known as: cancer of jugular body · jugular body cancer · malignant glomus jugulare neoplasm · malignant glomus jugulare tumor · malignant glomus jugulare tumour · malignant jugular body neoplasm · malignant jugulotympanic paraganglioma · malignant neoplasm of glomus jugulare · malignant neoplasm of jugular body · malignant neoplasm of the glomus jugulare · malignant tumor of glomus jugulare · malignant tumor of the glomus jugulare · malignant tumour of glomus jugulare · malignant tumour of the glomus jugulare

Disease family

This is a subtype of vascular cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › cardiovascular cancer › vascular cancer › malignant jugulotympanic paraganglioma

Related subtypes (6): choroid plexus cancer, adrenal cortex carcinoma, choroid cancer, epithelioid hemangioendothelioma, angiosarcoma, great vessel cancer

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.